LDS/Medical Tests/Lactate, CSF

Lactate, CSF

Lactate is a metabolite produced from pyruvate in the process of glycolysis in skeletal muscle, erythrocytes, brain, skin, kidney, and some other tissues. Increase in lactate causes lactic acidosis, which is associated with a variety of conditions. Lactic acidosis occurs in two forms, type A and type B. Type A is the most common form and occurs due to poor tissue oxygenation or severe tissue anoxia such as shock, cardiac arrest, severe anemia, and carbon monoxide poisoning. Type B occurs with no clinical evidence of inadequate tissue oxygen delivery; it can be due to drugs, inborn errors of metabolism, severe liver disease, or a metabolic myopathy and sepsis. Levels of lactate can increase and fall nearly instantly in some conditions. A 10- to 15-fold increase can be seen within seconds of strenuous exercise, and it is lowest during states of fasting.

Lactic acidosis should be suspected when there is a markedly increased anion gap (>18 meq/L), pH of less than 7.25, and in elevation of pCO2 in the absence of other causes (example: renal failure, ketosis, and ethanol, methanol or salicylate ingestion). Lactate levels are more recently being used in clinical considerations with trauma. Elevated lactate levels are seen in trauma patients due to the imbalance of oxygen in tissues. This can occur due to diminished tissue perfusion or decreased oxygen content in blood.

Hyperlactatemia is a common finding in these patients and it is associated with high mortality in trauma patients. Therefore, the measurement of blood lactate is an important tool to detect early tissue hypoxia in trauma patients who present with little or no serious symptoms. Measuring pyruvate levels in addition to lactate, and calculating the lactate-pyruvate ratio, helps in diagnosis of lactate acidosis and related diseases. The normal arterial concentration of lactate is around 1.5 mmol/L. The normal arterial concentrate of pyruvate is less than 0.15 mmol/L. The arterial lactate-pyruvate ratio is normally about 10:1 (1.5 mmol/L lactate: 0.15 mmol/L pyruvate). When lactic acidosis is present, the ratio may rise to 50:1.

  • Diagnosis of lactic acidosis
  • Diagnostically useful as a secondary assessment of oxygen levels in tissues
  • As a marker of tissue hypoperfusion in patients with circulatory shock
  • Differential diagnosis of metabolic acidosis of unknown etiology
  • As an aid in diagnosis of alcohol intoxication
  • As an aid in diagnosis of sepsis and shock
  • As an indicator of trauma

Increased in:

  • Trauma
  • Severe exercise
  • Ethanol ingestion
  • Sepsis
  • Shock
  • Liver disease
  • Diabetic ketoacidosis
  • Bowel ischemia
  • Mitochondrial myopathy
  • Encephalopathy
  • Stroke-like episodes
  • Type I glycogen storage disease
  • Pyruvate dehydrogenase deficiency
  • In some lymphomas such as non-Hodgkin and Burkitt lymphoma
  • Some drugs such as phenformin, metformin, isoniazid toxicity
  • HIV reverse transcriptase inhibitors

Decreased in:

  • Gross hemolysis usually due to specimen collection with and elevated LDH measurement
Specimen mg/dL mmol/L
Venous 8.1–15.3 0.9–1.7
Arterial <11.3 <1.3

Patient should be at complete rest.

Enzymatic, Gas Chromatography, Amperometric, Substrate-Specific Electrode.

Cerebrospinal fluid collected in a sterile container or tube. 

Stability

  • Ambient: 12 hours
  • Refrigerated: 3-5 days
  • Frozen: 30 days
Pyruvate, Lactate-pyruvate ratio, Electrolytes with Anion Gap, Serum Ethanol, Arterial pH, Arterial blood gases, Salicylate level, Liver Panel, Blood cultures, Blood glucose, Blood beta-hydroxybutyrate, Urine ketones.

1-3 days.

Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Thromb Res. 2011 Dec 3. [PMID: 22138415]
  • J Intern Med. 2004;255:179. [PMID: 14746555]
  • Intensive Care Med. 2005;20:255. [PMID: 16145217]
  • Narins RG et al. Hosp Pract. 1980; 91-8.
  • Anderson SC and Cockayne S. Clinical Chemistry: Concepts and Applications. Philadelphia. W.B. Saunders Company (1993).
  • Jacobs DS and DeMott WR. Laboratory Test Handbook. 5th. Hudson, OH. Lexi-Comp, Inc (2001).
  • http://www.vin.com/proceedings/Proceedings.plx?CID=WSAVA2009&Category=&PID=53790&O=Generic